Effect of monosodium glutamate on cognitive function in people with dementia

Effect of monosodium glutamate on cognitive function in people with dementia - Effect of monosodium glutamate on cognitive function in people with dementia

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000020573

Enrollment

200

Registered

2016-01-15

Start date

2014-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

dementia

Interventions

Subjects take a meal with 0.9g monosodium glutamate three times a day (breakfast, lunch and dinner) for three months. We perform tests three times (before intervention, after intervention and one mont

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1) Subjects with dementia 2) Subjects that informed consent was provided from the person and the relative

Exclusion criteria

Exclusion criteria: 1) Subjects who are diagnosed taste disturbance 2) Subjects who received chemotherapy within the past one year 3) Subjects who have been performed the dietary therapy for hypertension such as sodium restriction 4) Subjects who are assessed by the principal investigator due to other reasons

Design outcomes

Primary

Measure	Time frame
The result of Touch panel-type Dementia Assessment Scale (TDAS) just after intervention.	—

Secondary

Measure	Time frame
The results of Gottfries, Brane and Steen scale (GBSS), questionnaire and blood tests just after intervention.	—

Countries

Japan

Contacts

Public ContactMinoru Kouzuki

School of Health Science, Faculty of Medicine, Tottori University Department of Biological Regulation

kouzuki@med.tottori-u.ac.jp0859-38-6358

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026